how novel agents are transforming the treatment landscape of scd
Published 2 years ago • 52 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
1:43
the changing treatment landscape of pnh: novel agents and combinations
-
1:10
upcoming novel agents for the treatment of sickle cell disease
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
50:47
covid & plasma - naturally improve platelet count levels
-
21:02
artificial intelligence vs. cancer | cancer straight talk podcast
-
10:09
introduction phase - scd diet
-
1:15
bringing novel agents to the frontline setting in myeloma
-
2:09
integrating novel agents into the treatment of multiple myeloma
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
1:50
novel treatment regimens under investigation for richter's transformation
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:06
how will novel agents & car-t cells affect the future treatment landscape in b-all?
-
1:01
advancements in cml: improving treatment-free remission and novel agents